These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. T3-release from autonomously functioning thyroid nodules in vitro. Poertl S; Kirner J; Saller B; Mann K; Hoermann R Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030 [TBL] [Abstract][Full Text] [Related]
6. A comparison of plasma TSH levels in patients with diffuse and nodular non-toxic goiter. Toft AD; Irvine WJ; Hunter WM J Clin Endocrinol Metab; 1976 May; 42(5):973-6. PubMed ID: 1270586 [TBL] [Abstract][Full Text] [Related]
7. [Collagen content of the thyroid tissue and/urinary hydroxyproline in various forms of goiter]. Guseĭnov IA Probl Endokrinol (Mosk); 1981; 27(5):20-4. PubMed ID: 6895255 [TBL] [Abstract][Full Text] [Related]
8. [Role of blood coagulating and fibrinolytic compounds from thyroid tissue in the pathogenesis of increased hemorrhagic diathesis during operations for euthyroid and thyrotoxic goiter]. Liul'ka AN; Kovalev AP Klin Khir (1962); 1979 Dec; (12):38. PubMed ID: 522372 [No Abstract] [Full Text] [Related]
9. [Several kinin system indices in diseases of the thyroid gland]. Fesenko VP; Babalich AK Vopr Med Khim; 1978; 24(6):781-6. PubMed ID: 581624 [TBL] [Abstract][Full Text] [Related]
10. Activity of coagulation and fibrinolytic system components in the vein thrombus. Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310 [TBL] [Abstract][Full Text] [Related]
11. [Several aspects of the pathogenesis of disturbances of hemostasis in patients with diffuse toxic goiter]. Oleĭnik VA; Matiashina GI Ter Arkh; 1988; 60(9):43-6. PubMed ID: 3217879 [TBL] [Abstract][Full Text] [Related]
13. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter. Prendergast JJ; Miller JM Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196 [No Abstract] [Full Text] [Related]
14. [Fibrinolytic and fibrin-stabilizing properties of human tissues]. Skipetrov VP Gematol Transfuziol; 1989 Jun; 34(6):37-41. PubMed ID: 2806865 [TBL] [Abstract][Full Text] [Related]
16. [Histochemical characteristics of some oxidation-reduction hydrolytic enzymes in different forms of goiter]. Kasab'ian SS; Pisarev VB Probl Endokrinol (Mosk); 1976; 22(6):26-9. PubMed ID: 190604 [TBL] [Abstract][Full Text] [Related]
17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
18. [Effect of thyroid hormones on calcitonin secretion]. Rom-Bugoslavskaia ES; Gopkalova IV Probl Endokrinol (Mosk); 1988; 34(6):9-13. PubMed ID: 3237673 [TBL] [Abstract][Full Text] [Related]
19. Blood levels of cystine aminopeptidase (oxytocinase) in patients with toxic and simple goiter. Klimek R; Malolepszy E Clin Chim Acta; 1968 Dec; 22(4):491-5. PubMed ID: 5755007 [No Abstract] [Full Text] [Related]